Lundkvist, P., Pereira, M
We recommend drawing each dose fresh from the glass vial right before use
As a 2022 report noted, "obesity remains the most important risk factor for the incidence and progression of osteoarthritis." According to Bliddal, the researchers launched the study to answer this question: "Would a highly effective anti-obesity medication improve KOA to a clinically meaningful degree?" Other studies had tackled the question with inconsistent results, he said
The completion of the trial allows Lilly to seek regulatory approval and potentially launch the next-generation drug in 2027 as it competes with Novo Nordisk in the obesity treatment market
Week 812 What you may notice: Endpoint of most protocols
Draw the prescribed dose using an 18-gauge draw needle, then switch to a 25-gauge 1-inch injection needle for intramuscular administration